Garland J. Scott
SEC insider (Form 3/4/5 filer). CIK 0001533228. Director at Enliven Therapeutics, Inc. (ELVN) and 4 other issuers. 30 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in BURLINGAME, CA.
Companies Garland J. Scott has filed insider reports for
- Enliven Therapeutics, Inc. (ELVN): Director
- Olema Pharmaceuticals, Inc. (OLMA): Director
- LB PHARMACEUTICALS INC (LBRX): Director
- Day One Biopharmaceuticals, Inc. (DAWN): Director
- ALX ONCOLOGY HOLDINGS INC (ALXO): Director
Garland J. Scott
CIK: 0001533228
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (30 total)
- Oct 1, 2026ELVN
Enliven Therapeutics, Inc.
SaleDirect13K shares at avg. $46.67$607K - Oct 1, 2026ELVN
Enliven Therapeutics, Inc.
ExerciseDirect13K shares at avg. $15.47$201K - Jun 18, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
29.5K shares- - Jun 3, 2026LBRX
LB PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
10K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionDirectStock Option (right to buy Common Stock)
28.7K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionDirectStock Option (right to buy Common Stock)
37.5K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionDirectStock Option (right to buy Common Stock)
48.1K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionDirectStock Option (right to buy Common Stock)
22.5K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionDirectRestricted Stock Unit (RSU)
15K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionDirectStock Option (right to buy Common Stock)
32.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  ELVN Enliven Therapeutics, Inc. | Sale | 13,000 | $46.67 | $606,719 | Direct |
| Oct 1, 2026 | ELVN Enliven Therapeutics, Inc. | Exercise | 13,000 | $15.47 | $201,110 | Direct |
| Jun 18, 2026 |  OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 29,500 | - | - | Direct |
| Jun 3, 2026 |  LBRX LB PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Apr 23, 2026 |  DAWN Day One Biopharmaceuticals, Inc. | Disposition Stock Option (right to buy Common Stock) | 28,700 | - | - | Direct |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition Stock Option (right to buy Common Stock) | 37,500 | - | - | Direct |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition Stock Option (right to buy Common Stock) | 48,072 | - | - | Direct |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition Stock Option (right to buy Common Stock) | 22,500 | - | - | Direct |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition Restricted Stock Unit (RSU) | 15,000 | - | - | Direct |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition Stock Option (right to buy Common Stock) | 32,335 | - | - | Direct |
1-10 of 30 transactions